Lifelong Learning: The Annual Psychiatric Times® World CME Conference™
February 20th 2020With the emergence of new therapeutic strategies and as the field of psychiatry continues to progress, it is important to keep up with the explosion of available treatments, starting with our upcoming 3-day CME meeting.
Year in Review: 2019 Special Reports in Psychiatry
December 2nd 2019As varied as the field of psychiatry itself, our Special Report collections covered issues such as eating disorders, traumatic brain injury, practice management, schizophrenia and depression, complex medical comorbidities, and more. Here's a sampling.
Multidisciplinary Team Explores Link Between Asthma and Depression
August 16th 2019In a first-of-its-kind study, researchers from the Icahn School of Medicine at Mount Sinai, Montefiore Health System, and Albert Einstein College of Medicine are working together to examine the link between depression and asthma in older adults.
CDC Report Finds ADHD Diagnosis, Treatment in Children and Adolescents Continue to Rise
December 4th 2013ADHD is on the rise according to a new report from the CDC, and most youngsters with the diagnosis are receiving treatment for the disorder. But the report raises a number of clinical implications . . .
Modest-But Clinically Useful-Changes for Psychotic Disorders in DSM-5
October 4th 2013This member of the DSM-5 Work Group for Psychotic Disorders describes the 8 dimensions used to define the presentation of psychosis-the biggest and most clinically important of the changes in the schizophrenia and other psychotic disorders section.
Limited Progress Made in Schizophrenia Understanding and Treatment
October 4th 2013You’ve come a long way, baby. But maybe not long enough, according to Dr Rajiv Tandon, who shared the evolution of schizophrenia diagnosis and highlighted the current status for attendees at the US Psychiatric and Mental Health Congress.
From the Streets to the Rx Pad: Do Party Drugs Have a Place in the Medical Office?
October 3rd 2013Can drugs be categorized as good (eg, medicinal), bad (eg, recreational with deleterious side effects and addiction issues), or is there a middle ground? That was the underlying theme in a lecture at PsychCongress, “Perils and Promise of Psychoactive Drugs: A Focus on Harm Reduction Psychiatry.”
Mass Murderers: Lack of Communication and Myths May Hinder Recognition
October 1st 2013Lack of communication is often a key factor in mass murder, according Phillip Resnick, MD. Although HIPAA is important, the safety of the individual and the public should outweigh privacy issues, and “risk to human life always trumps confidentiality.”
Take a Cup o’ Joe and Call Me in the Morning-Coffee Consumption Linked to Lower Suicide Risk
September 13th 2013Most people look forward to their morning jolt from coffee, but could that cup of Joe be doing more than keeping us alert? According to researchers from Harvard University, java may indeed have another benefit-that of reducing suicide risk.
Parity Laws: Powerful Weapon-or Pipe Dream?
May 6th 2013Has the Mental Health Parity and Addiction Equity had any real impact on your ability to provide care to patients, or are you experiencing the shells and mortars of paperwork and denials? And will the average patient ever really benefit from the laws, or were they just passed to make the country feel better about the state of psychiatric care in the US?